The United States has launched a formal investigation into Germany under Section 301 of the Trade Act of 1974, examining whether the country’s pricing policies for innovative pharmaceutical products are discriminatory
trade agreement as a transformative moment for American exporters. While the formal legal text is currently being finalized, Greer confirmed that the core specifics...
